The value of magnetic resonance imaging for radiotherapy planning

Piet Dirix; Karin Haustermans; Vincent Vandecaveye

doi:10.1016/j.semradonc.2014.02.003

The value of magnetic resonance imaging for radiotherapy planning

Semin Radiat Oncol. 2014 Jul;24(3):151-9. doi: 10.1016/j.semradonc.2014.02.003.

Authors

Piet Dirix¹, Karin Haustermans², Vincent Vandecaveye³

Affiliations

¹ Department of Radiation Oncology, Leuvens Kankerinstituut (LKI), University Hospitals Leuven, Leuven, Belgium; Department of Radiology, Leuvens Kankerinstituut (LKI), University Hospitals Leuven, Leuven, Belgium. Electronic address: piet.dirix@uzleuven.be.
² Department of Radiation Oncology, Leuvens Kankerinstituut (LKI), University Hospitals Leuven, Leuven, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium.
³ Department of Radiology, Leuvens Kankerinstituut (LKI), University Hospitals Leuven, Leuven, Belgium; Department of Imaging & Pathology, KU Leuven, Leuven, Belgium.

PMID: 24931085
DOI: 10.1016/j.semradonc.2014.02.003

Abstract

The success of highly conformal radiotherapy techniques in the sparing of normal tissues or in dose escalation, or both, relies heavily on excellent imaging. Because of its superior soft tissue contrast, magnetic resonance imaging is increasingly being used in radiotherapy treatment planning. This review discusses the current clinical evidence to support the pivotal role of magnetic resonance imaging in radiation oncology.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Contrast Media
Humans
Magnetic Resonance Imaging / methods*
Magnetic Resonance Imaging, Interventional
Radiation Oncology / methods*
Radiotherapy Planning, Computer-Assisted*
Radiotherapy, Conformal
Radiotherapy, Image-Guided

Substances

Contrast Media